Medtronic (MDT) closed at $101.72 in the latest trading session, marking a -1.15% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.47% for the day. On the other hand, the Dow registered a gain of 0.04%, and the technology-centric Nasdaq increased by 0.9%.
Shares of the medical device company have appreciated by 5.51% over the course of the past month, outperforming the Medical sector's gain of 2.92%, and the S&P 500's loss of 0.16%.
The upcoming earnings release of Medtronic will be of great interest to investors. The company's earnings report is expected on February 17, 2026. The company's earnings per share (EPS) are projected to be $1.33, reflecting a 4.32% decrease from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $8.9 billion, indicating a 7.29% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $5.64 per share and revenue of $36.04 billion, which would represent changes of +2.73% and +7.46%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Medtronic. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Medtronic is currently a Zacks Rank #4 (Sell).
From a valuation perspective, Medtronic is currently exchanging hands at a Forward P/E ratio of 18.24. This indicates a discount in contrast to its industry's Forward P/E of 20.5.
It's also important to note that MDT currently trades at a PEG ratio of 2.71. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Medical - Products stocks are, on average, holding a PEG ratio of 1.45 based on yesterday's closing prices.
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 174, this industry ranks in the bottom 29% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Medtronic PLC (MDT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
